SYNRIAM ANTI-MALARIA
Medicines
Antimalaria
₦13100.00
In Stock (10 units)
Description
Synriam (150 mg/750 mg) is an oral, fixed-dose, prescription antimalarial combination of arterolane maleate and piperaquine phosphate, used to treat acute, uncomplicated Plasmodium falciparum malaria. Developed in India by Ranbaxy (now part of Sun Pharmaceutical), it is highly effective, often taking a 3-day course.
100% Authentic Products
You might also like
